$BlackBerry(BB)$ back in the game! 1. Rising Short Interest: BlackBerry currently has 29.49 million shares sold short, representing 5.09% of its public float. This short interest increased slightly (+0.96%) from the previous month, suggesting that bearish sentiment remains, but it hasn’t spiked massively. The short interest ratio, or days to cover, stands at 5.0, meaning it would take 5 days for short sellers to buy back shares based on the average trading volume. This is notable because days-to-cover ratios above 3 typically indicate vulnerability to a short squeeze. 2. Trading Volume: On October 1, 2024, BlackBerry experienced a surge in trading volume—12.82 million shares traded, which is 208% higher than its avera
$Zomedica Pharmaceuticals Corp.(ZOM)$ Another shortsqueeze top pick! Zomedica (ZOM) has recently been a topic of discussion among traders due to its high short interest, which makes it a potential candidate for a short squeeze. As of end September 2024, Zomedica had over 43 million shares shorted, accounting for 4.5% of its float, with a "days to cover" ratio of 14.2. This indicates a significant level of short interest compared to the average trading volume, and it would take about two weeks for all short positions to be covered, which could fuel a squeeze if momentum builds. Despite some improvements, like a reduction in short interest by 11.9% since the previous month, the stock is still heavily shorted. Moreover, Zomedica's recent operational
$BlackBerry(BB)$my take, crypto is the new payment method. Most practival place to store digital assets and make payment will be your phone. I believe that bb may be the strongest contender in this scenario.
$BlackBerry(BB)$ Momentum shift Following up with the latest technical suggests that it's currently consolidating around key support levels. In the past six months, the stock has seen fluctuations, with its price recently hovering near $2.43 as of October 2, 2024. The stock has been below its 50-day moving average, and is approaching levels that could trigger a reversal if buyers step in. Momentum indicators like the relative strength index (RSI) are nearing oversold levels, which often precedes a rebound. Furthermore, the moving average convergence divergence (MACD) indicates that while the stock is still in a downward trend, there might be a turn around in momentum. One factor to watch closely is short int
$Zomedica Pharmaceuticals Corp.(ZOM)$Displaying signs of buyout. Products at the and besides being so hype about the product but suddenly dead silent at the introductory stage...